Comparison of efficacy and safety profile of allogeneic versus autologous cd19 chimeric antigen receptor t cell therapy in hematological malignancies: A systematic review and meta-analysis

Category Systematic review
JournalBlood
Year 2021
This article has no abstract
Epistemonikos ID: 4153866a43201683a62efbf1378cc98d462ab263
First added on: Feb 13, 2025